Achieve Life Sciences, Inc.
ACHVNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $606.88M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $2.62$8.64
- Volume (live)
- -
- Avg. volume (3M)
- 1.47M
Achieve Life Sciences (ACHV) Stock Price & Financial Analysis
Achieve Life Sciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.36 - $6.61 |
|---|---|
| 52-Week High | $8.64 |
| 52-Week Low | $2.62 |
| Open | $6.48 |
| Volume (last close) | 590.13K |
| Average Volume (3M) | 1.47M |
| 50-Day MA | $7.57 |
|---|---|
| 200-Day MA | $5.59 |
| 1-Year Change | +32.11% |
| Market Cap | 606.88M |
|---|---|
| Shares Outstanding | 93.51M |
| Price to Book (P/B) | -41.35 |
| EV/EBITDA | -5.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Achieve Life Sciences at a Glance
As of the Oct 23, 2026 close, Achieve Life Sciences (ACHV) has a market capitalization of $606.88M.
As of its latest reported balance sheet, it holds $47.96M in cash and securities against $14.91M of debt, a net cash position of $33.05M.
Achieve Life Sciences does not currently pay a dividend.
The share price is up 32.1% over the past year. At $6.49 (the Oct 23, 2026 close) it sits within its 52-week range of $2.62 to $8.64, above its 200-day moving average of $5.59.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $13.83, 113.1% above the Oct 23, 2026 close.
Frequently Asked Questions About Achieve Life Sciences
What is the current stock price for ACHV?
As of the Oct 23, 2026 close, ACHV stock trades at $6.49. The 52-week range is $2.62–$8.64, with a day range of $6.36–$6.61.
What is the P/E ratio for ACHV?
The P/E ratio (Price-to-Earnings) for ACHV is shown in the Key Statistics section. This valuation metric helps compare Achieve Life Sciences, Inc. to industry peers.
Does ACHV pay dividends?
Achieve Life Sciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ACHV?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for ACHV is Buy. The average 12-month price target is $13.83, a 113.1% upside from the Oct 23, 2026 close of $6.49.
What is the market cap of ACHV?
As of the Oct 23, 2026 close, Achieve Life Sciences's market capitalization is $606.9M, classifying it as a small-cap company. Achieve Life Sciences operates in the Healthcare sector within the Biotechnology industry.